When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA-approved drug for ulcerative colitis also effective for ...

   www.aol.com/fda-approved-drug-ulcerative-colitis...

   Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.

3. Crohn’s disease is a lifelong condition, but proper treatment ...

   www.aol.com/crohn-disease-lifelong-condition...

   Historically, before there were effective medications for the treatment of Crohn’s disease, the majority of Crohn’s patients needed surgery to address complications that would inevitably arise ...

4. Management of Crohn's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Crohn's_disease

   Maintenance of remission after surgery for Crohn's disease [12] A combination of azathioprine and infliximab treatment may be more effective than a single dose of infliximab to induce steroid-free remission for people with active Crohn's disease. [9] Azathioprine treatment may lead to rare but life-threatening side effects.

5. Giving Crohn’s drug early ‘cuts need for surgery and further ...

   www.aol.com/giving-crohn-drug-early-cuts...

   Ruth Wakeman, director of services, advocacy and evidence at Crohn’s & Colitis UK, said: “Crohn’s disease affects over 200,000 people in the UK and we know that many of them have symptoms ...

6. Vedolizumab - Wikipedia

   en.wikipedia.org/wiki/Vedolizumab

   Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Takeda Oncology for the treatment of ulcerative colitis and Crohn's disease. [5] It binds to integrin α 4 β 7 ( LPAM-1 , lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7 ), [ 5 ] [ 6 ] blocking the α 4 ...

7. Biological therapy for inflammatory bowel disease - Wikipedia

   en.wikipedia.org/wiki/Biological_therapy_for...

   It was found to have efficacy over placebo medications for 10 weeks in the treatment of moderate to severe Crohn's disease in one large trial. [27] It is not used in the treatment of ulcerative colitis, but it is used in the treatment of rheumatoid arthritis, active psoriatic arthropathy, and ankylosing spondylitis. [11]